Related references
Note: Only part of the references are listed.Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway
Dongbin Lyu et al.
PSYCHOPHARMACOLOGY (2022)
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials
Robson Zazula et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2021)
The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression
Naoise Mac Giollabhui et al.
MOLECULAR PSYCHIATRY (2021)
N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Fabiano G. Nery et al.
BIPOLAR DISORDERS (2021)
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies
Wolfgang Marx et al.
MOLECULAR PSYCHIATRY (2021)
Dysregulation of Protein Kinase C in Adult Depression and Suicide: Evidence From Postmortem Brain Studies
Ghanshyam N. Pandey et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression
Nunzio Pomara et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
P2X7R antagonists in chronic stress-based depression models: a review
Iven-Alex von Muecke-Heim et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review
Emma Kopra et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19 A Meta-analysis
Nicole Racine et al.
JAMA PEDIATRICS (2021)
Innate immunity receptors in depression and suicide: upregulated NOD-like receptors containing pyrin (NLRPs) and hyperactive inflammasomes in the postmortem brains of people who were depressed and died by suicide
Ghanshyam N. Pandey et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2021)
Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far
Michael Roman et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders
Gayle M. Wittenberg et al.
MOLECULAR PSYCHIATRY (2020)
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
Gender Differences in Depression: Evidence From Genetics
Lihong Zhao et al.
FRONTIERS IN GENETICS (2020)
Depression and inflammation among children and adolescents: A meta-analysis
Marlena Colasanto et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
Daniela Enache et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
P2X7 Receptor Signaling in Stress and Depression
Deidiane Elisa Ribeiro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine
Gong Wenqing et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Prevalence and socioeconomic impact of depressive disorders in India: multisite population-based cross-sectional study
Banavaram Anniappan Arvind et al.
BMJ OPEN (2019)
Glucocorticoid-Driven NLRP3 Inflammasome Activation in Hippocampal Microglia Mediates Chronic Stress-Induced Depressive-Like Behaviors
Xiujing Feng et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
P2X7 receptors are involved in stress-related behaviours and antidepressant effect
D. E. Ribeiro et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
N. Kappelmann et al.
MOLECULAR PSYCHIATRY (2018)
Kynurenine pathway metabolism and the neurobiology of treatment resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy
A. P. Allen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Purinergic modulation of glutamate transmission: An expanding role in stress-linked neuropathology
J. Mayhew et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2x2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
Jonathan B. Savitz et al.
TRANSLATIONAL PSYCHIATRY (2018)
T cell Phenotype and T cell receptor repertoire in Patients with Major Depressive Disorder
Kostas Patas et al.
FRONTIERS IN IMMUNOLOGY (2018)
n-3 Docosapentaeno c acid-derived protectin DI promotes resolution of neuroninflammation and arrests epileptogenesis
Federica Frigerio et al.
BRAIN (2018)
Prevalence of Depression in the Community from 30 Countries between 1994 and 2014
Grace Y. Lim et al.
SCIENTIFIC REPORTS (2018)
Pro-resolving mediator maresin 1 ameliorates pain hypersensitivity in a rat spinal nerve ligation model of neuropathic pain
Jie Gao et al.
JOURNAL OF PAIN RESEARCH (2018)
Role of Adiposity-Driven Inflammation in Depressive Morbidity
Lucile Capuron et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Decreased Prostaglandin D2 Levels in Major Depressive Disorder Are Associated with Depression-Like Behaviors
Cuilin Chu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review
Myrela O. Machado et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Heterozygosity for the Mood Disorder-Associated Variant Gln460Arg Alters P2X7 Receptor Function and Sleep Quality
Michael W. Metzger et al.
JOURNAL OF NEUROSCIENCE (2017)
Recurrence of depressive disorders after interferon-induced depression
W-C Chiu et al.
TRANSLATIONAL PSYCHIATRY (2017)
Regulation of Hippocampal 5-HT Release by P2X7 Receptors in Response to Optogenetic Stimulation of Median Raphe Terminals of Mice
Flora Goloncser et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Monoamine involvement in the antidepressant-like effect induced by P2 blockade
Cassiano R. A. F. Diniz et al.
BRAIN RESEARCH (2017)
Ketamine Alleviates Depressive-Like Behaviors via Down-Regulating Inflammatory Cytokines Induced by Chronic Restraint Stress in Mice
Sijie Tan et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings
Fernanda N. Kaufmann et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model
Wen-Jun Su et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia/reperfusion injury by attenuating the pro-inflammatory response
Wenjing Xian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder
Timothy B. Meier et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression
Ren-Hong Du et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Effects of antidepressants on P2X7 receptors
Wei Wang et al.
PSYCHIATRY RESEARCH (2016)
Protein kinase C in the immune system: from signalling to chromatin regulation
Pek Siew Lim et al.
IMMUNOLOGY (2015)
Levodopa Reverses Cytokine-Induced Reductions in Striatal Dopamine Release
Jennifer C. Felger et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial
Amirhossein Gougol et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Paroxetine suppresses recombinant human P2X7 responses
Phuong Dao-Ung et al.
PURINERGIC SIGNALLING (2015)
Mitochondria: diversity in the regulation of the NLRP3 inflammasome
Prajwal Gurung et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder
Jonathan Savitz et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Structural mechanisms in NLR inflammasome signaling
Bernhard C. Lechtenberg et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)
Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury
Juan Pablo de Rivero Vaccari et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Resolvin D1, a Metabolite of Omega-3 Polyunsaturated Fatty Acid, Decreases Post-Myocardial Infarct Depression
Kim Gilbert et al.
MARINE DRUGS (2014)
Dexamethasone Protects Neonatal Hypoxic-Ischemic Brain Injury via L-PGDS-Dependent PGD2-DP1-pERK Signaling Pathway
Pablo J. Gonzalez-Rodriguez et al.
PLOS ONE (2014)
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture
Ewa Obuchowicz et al.
PHARMACOLOGICAL REPORTS (2014)
Bupropion pre-treatment of endotoxin-induced depressive symptoms
Nicole DellaGioia et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Interleukin-1β inhibits the differentiation of hippocampal neural precursor cells into serotonergic neurons
Kun Zhang et al.
BRAIN RESEARCH (2013)
AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL
Ahmad Ghanizadeh et al.
DEPRESSION AND ANXIETY (2013)
Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxide
Vitor S. Pereira et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Human astrocytes express a novel NLRP2 inflammasome
Julia Minkiewicz et al.
GLIA (2013)
CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
Vyara Valkanova et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder
Daimei Sasayama et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder
Jae-Won Kim et al.
PSYCHIATRY INVESTIGATION (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Inflammasomes and Their Roles in Health and Disease
Mohamed Lamkanfi et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 28 (2012)
Novel therapeutic targets in depression: Minocycline as a candidate treatment
Joanna K. Soczynska et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
Charles N. Serhan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Targeting IL-1 in depression
Michael Maes et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Circulating cytokine concentrations are not associated with major depressive disorder in a community-based cohort
Gunnar Einvik et al.
GENERAL HOSPITAL PSYCHIATRY (2012)
Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1
Olaf Gross et al.
IMMUNITY (2012)
Interleukin-6, a Major Cytokine in the Central Nervous System
Maria Erta et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology
Claudia Ditzen et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial
Khatereh Sepanjnia et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes
S. J. Sukoff Rizzo et al.
TRANSLATIONAL PSYCHIATRY (2012)
DOUBLE-BLIND RANDOMIZED PARALLEL-GROUP CLINICAL TRIAL OF EFFICACY OF THE COMBINATION FLUOXETINE PLUS MODAFINIL VERSUS FLUOXETINE PLUS PLACEBO IN THE TREATMENT OF MAJOR DEPRESSION
Roya Abolfazli et al.
DEPRESSION AND ANXIETY (2011)
Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice
Jason Hellmann et al.
FASEB JOURNAL (2011)
Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies
Brian Dean
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice
Ewa Poleszak et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis
Xiaoyin Niu et al.
MOLECULAR IMMUNOLOGY (2011)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
M. Berk et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats
Ying Wang et al.
NEUROSCIENCE LETTERS (2011)
Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
Laura Campbell et al.
RHEUMATOLOGY (2011)
A prospective evaluation of the directionality of the depression-inflammation relationship
Jesse C. Stewart et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
CLINICAL TRIAL OF ADJUNCTIVE CELECOXIB TREATMENT IN PATIENTS WITH MAJOR DEPRESSION: A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL
Shahin Akhondzadeh et al.
DEPRESSION AND ANXIETY (2009)
Plasma CRP Levels in Premenopausal Women with Major Depression: A 12-Month Controlled Study
G. Cizza et al.
HORMONE AND METABOLIC RESEARCH (2009)
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Corinne Cayrol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Depressive Symptoms and Metabolic Syndrome: Is inflammation the Underlying Link?
Lucile Capuron et al.
BIOLOGICAL PSYCHIATRY (2008)
Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum
Elizabeth J. Corwin et al.
BIOLOGICAL RESEARCH FOR NURSING (2008)
The TNF-α system:: Functional aspects in depression, narcolepsy and psychopharmacology
Mark Berthold-Losleben et al.
CURRENT NEUROPHARMACOLOGY (2008)
Central prostaglandin D2 stimulates food intake via the neuropeptide Y system in mice
Kousaku Ohinata et al.
FEBS LETTERS (2008)
New insights into the early molecular events underlying B cell activation
Naomi E. Harwood et al.
IMMUNITY (2008)
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Triin Eller et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
How TNF was recognized as a key mechanism of disease
Ian A. Clark
CYTOKINE & GROWTH FACTOR REVIEWS (2007)
Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep
Wei-Min Qu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha activate serotonin transporters
Chong-Bin Zhu et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
Cardiovascular outcomes in new users of coxibs and nonsteroidal Antiinflammatory drugs -: High-risk subgroups and time course of risk
. Daniel H. Solomon et al.
ARTHRITIS AND RHEUMATISM (2006)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
Unkind cytokines: Current evidence for the potential role of cytokines in immune-mediated depression
ML Pucak et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2006)
The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway
M Maes et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
H Ito et al.
GASTROENTEROLOGY (2004)
P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices
L Papp et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients
D Akin et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Raised plasma levels of tumor necrosis factor α in patients with depression -: Normalization during electroconvulsive therapy
KA Hestad et al.
JOURNAL OF ECT (2003)
Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone
A Schuld et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
Tumor necrosis factor signaling
H Wajant et al.
CELL DEATH AND DIFFERENTIATION (2003)
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
M Wichers et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-γ production
S Kumar et al.
CYTOKINE (2002)
Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors
K Fujino et al.
NEUROSCIENCE LETTERS (2002)
T-helper-1 and t-helper-2 responses in psychiatric disorders
MJ Schwarz et al.
BRAIN BEHAVIOR AND IMMUNITY (2001)
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study
C DeBattista et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
NF-kappa B determines between apoptosis and proliferation in hepatocytes during liver regeneration
J Plumpe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
Share Paper
